CoChat

Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes

Albarracin, Cesar A., Fuqua, Burcham C., Evans, Joseph L., Goldfine, Ira D. · 2008 · Diabetes/Metabolism Research and Reviews
Cited by 128

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background: Chromium and biotin play essential roles in regulating carbohydrate metabolism. This randomized, double‐blind, placebo‐controlled study evaluated the efficacy and safety of the combination of chromium picolinate and biotin on glycaemic control. Methods: Four hundred and forty‐seven subjects with poorly controlled type 2 diabetes (HbA 1c≥ 7.0%) were enrolled and received either chromium picolinate (600 µg Cr+3) with biotin (2 mg), or matching placebo, for 90 days in combination with stable oral anti‐diabetic agents (OADs). Major endpoints were reductions in HbA 1c, fasting glucose, and lipids. Safety and tolerability were assessed. Results: Change in HbA 1c was significantly different between treatment groups (p= 0.03). HbA 1c in the chromium picolinate/biotin group decreased 0.54%. The decrease in HbA 1c was most pronounced in chromium picolinate/biotin subjects whose baseline HbA 1c≥ 10%, and highly significant when compared with placebo (−1.76%vs− 0.68%;p= 0.005). Fasting glucose levels were reduced in the entire chromium picolinate/biotin group versus placebo (−9.8 mg/dL vs 0.7 mg/dL;p= 0.02). Reductions in fasting glucose were also most marked in those subjects whose baseline HbA 1c≥ 10.0%, and significant when compared to placebo (−35.8 mg/dL vs.16.2 mg/dL;p= 0.01). Treatment was well tolerated with no adverse effects dissimilar from placebo. Conclusions: These results suggest that the chromium picolinate/biotin combination, administered as an adjuvant to current prescription anti‐diabetic medication, can improve glycaemic control in overweight to obese individuals with type 2 diabetes; especially those patients with poor glycaemic control on oral therapy. Copyright © 2007 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/dmrr.755

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 128

Metadata

Authors
Albarracin, C. A., Fuqua, B. C., Evans, J. L., & Goldfine, I. D.
Venue
Diabetes/Metabolism Research and Reviews
Publisher
Wiley
Published
2007-05-16
Volume
24
Issue
1
Pages
41-51
ISSN
  • 1520-7552 (ISSN-L)
  • 1520-7560
OpenAlex
W1969585124
Cited by
128
References
5
FWCI
6.72
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. https://app.cochat.ai/papers/10.1002/dmrr.755
The paper
Albarracin, C. A., Fuqua, B. C., Evans, J. L., & Goldfine, I. D. (2008). Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.755

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.